Optical Coherence Tomography in Retinal Vein Occlusion

Optical Coherence Tomography Data As a Prognostic Indicator in Retinal Vein Occlusion

Status

Not yet recruiting

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT06886893

Enrollment

Registered

2025-03-20

Start date

2025-05-01

Completion date

2026-12-30

Last updated

2025-03-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Optical Coherence Tomography (OCT)

Keywords

OCT, retinal vein occlusion

Brief summary

This study aims to evaluate how optical coherence tomography (OCT) can help predict outcomes in patients with retinal vein occlusion (RVO), a condition that affects blood flow in the retina. RVO can cause macular edema, which is swelling in the part of the eye responsible for central vision. The study will use OCT scans to assess changes in the retina and how these changes relate to vision improvement over time.

Detailed description

Objectives Evaluate how OCT data can predict visual outcomes by analyzing retinal changes and macular edema characteristics. Assess the correlation between baseline OCT biomarkers and visual acuity improvements over time. Study Design Type: Cross-sectional study. Setting: Conducted at several eye care centers in Egypt. Participants Inclusion Criteria: Adults with branch or central RVO, macular edema confirmed by OCT, and no prior RVO in the affected eye. Exclusion Criteria: Other retinal diseases, recent intraocular surgery, or significant media opacities. Procedures Informed Consent and History Taking. Ophthalmologic Examination: Includes BCVA, IOP, slit-lamp biomicroscopy, and fundus examination. OCT Imaging: Using NIDEK RS-330 Retina scan duo 2 (SD-OCT) to assess macular changes. OCT Image Evaluation: Classification of macular edema types and assessment of biomarkers like subretinal fluid and cystoid changes.

Interventions

None listed

Study design

Observational model

COHORT

Time perspective

CROSS_SECTIONAL

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

* Adults aged 18 years or older. Patients diagnosed with branch or central retinal vein occlusion. Patients with macular edema confirmed by OCT due to vein occlusion. Patients with no prior history of RVO in the affected eye.

Exclusion criteria

* Presence of other retinal diseases that could affect OCT interpretation (e.g., diabetic retinopathy, age-related macular degeneration). History of intraocular surgery within the last three months. Presence of significant media opacities (e.g., dense cataract, vitreous hemorrhage) that interfere with OCT imaging.

Design outcomes

Primary

Measure	Time frame	Description
changes in OCT biomarkers and visual acuity post-treatment.	6 months	Correlation between baseline OCT biomarkers and visual acuity at presentation after 1, 3, and 6 months post-treatment.

Outcome results